Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria (Q34140513)

31 July 2017

Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria (English)

1 reference

31 July 2017

Gram-negative bacteria

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

urinary tract infection

1 reference

Ann Pallett

1

1 reference

PubMed ID

20876625

31 July 2017

Kieran Hand

series ordinal

2

1 reference

PubMed ID

20876625

31 July 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Journal of Antimicrobial Chemotherapy

31 July 2017

1 reference

31 July 2017

65 Suppl 3

1 reference

31 July 2017

iii25-33

1 reference

Complicated urinary tract infection in adults

31 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

A practical guide to antimicrobial management of complicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

A practical guide to the management of complicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Asymptomatic bacteriuria in elderly patients: significance and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

CTX-M: changing the face of ESBLs in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Activity of mecillinam against ESBL producers in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Properties and potential of ertapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Comparative review of the carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

Doripenem: a review of its use in the treatment of bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ298

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ298

1 reference

31 July 2017

1 reference

PubMed ID

20876625